Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal AntibodiesNeurol 92:663-674, Johansen, A.,et al, 2019
Neurotoxicity of Commonly Used Antineoplastic AgentsNEJM 291:75, 1271974., Weiss,H.,et al, 1974